$1.51
2.27% today
Nasdaq, Feb 28, 08:06 pm CET
ISIN
US83548R1059
Symbol
SONN
Sector
Industry

Sonnet BioTherapeutics Holdings Inc Target price 2025 - Analyst rating & recommendation

Sonnet BioTherapeutics Holdings Inc Classifications & Recommendation:

Buy
100%

Sonnet BioTherapeutics Holdings Inc Price Target

Target Price $20.00
Price $1.54
Potential
Number of Estimates 1
1 Analyst has issued a Sonnet BioTherapeutics Holdings Inc price target 2026. The average Sonnet BioTherapeutics Holdings Inc target price is $20.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Sonnet BioTherapeutics Holdings Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sonnet BioTherapeutics Holdings Inc stock has an average upside potential 2026 of . Most analysts recommend the Sonnet BioTherapeutics Holdings Inc stock at Purchase.

Current Sonnet BioTherapeutics Holdings Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Chardan Capital Locked ➜ Locked Locked Dec 20 2024
Chardan Capital Locked ➜ Locked Locked Aug 23 2024
Analyst Rating Date
Locked
Chardan Capital: Locked ➜ Locked
Dec 20 2024
Locked
Chardan Capital: Locked ➜ Locked
Aug 23 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today